The global left atrial appendage closure device market revenue was around US$ 1.8 billion in 2021 and is estimated to reach US$ 8.7 billion by 2031, growing at a compound annual growth rate (CAGR) of ...

VeriSight Pro 3D ICE catheter is a pioneering innovation — a miniaturized ultrasound probe embedded at the tip of a thin, ...

Congestion is the predominant cause of heart failure symptoms and hospitalization. In this Review, Testani and colleagues discuss established and emerging medical and device strategies to treat ...

Doctors at OhioHealth Mansfield Hospital celebrated their 500th procedure to help reduce the risk of stroke in patients with ...

King Faisal Hospital has successfully carried out Rwanda's first percutaneous closure of a patent foramen ovale (PFO), a rare catheter-based heart procedure performed on a stroke patient.The procedure ...

Koninklijke Philips N.V. (NYSE:PHG) introduced VeriSight Pro 3D Intracardiac Echocardiography (ICE) catheter in Europe, ...

What the team at Tufts detected was incredibly rare.“I feel like the whole thing happened so that I could have them checked,” ...

Sohail et al. present a retrospective review of 189 cases of cardiac device infection (CDI) who presented at the Mayo Clinic, MN, between January 1991 and December 2003. They propose new treatment ...

The acquired assets include Cardionomic’s Cardiac Pulmonary Nerve Stimulation ... that utilize a large access site. The LockeT closure device is optimal for the large bore puncture sites like ...

and left atrial appendage closure devices. Boston's coronary stent business is less moaty than its cardiac rhythm management segment. Boston's halt of its development of the Millipede product ...

These "cryptogenic" strokes may in some instances be due to an embolus traveling through a right-to-left shunt in the heart ... benefit of a percutaneous closure device for preventing further ...